ASTH
Astrana Health, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$36.62
−0.14%Year over year
Reported trailing growth
- Revenue
- +58.9%
- EBITDA
- +69.9%
- EBIT
- +43.4%
- EPS
- +56.2%
- Free cash flow
- +30.7%
- Operating cash flow
- +34.8%
Forward estimates
Based on analyst estimates
- Revenue
- +11.8%
- EBITDA
- +42.2%
- EPS
- +120.6%
Three-year CAGR
- Revenue
- +40.6%
- EBITDA
- +6.5%
- EBIT
- -9.0%
- Net income
- -20.7%
- EPS
- -22.8%
- Free cash flow
- +20.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026